RARE DISEASERESEARCH ATLAS

ORPHA:493342

Vibratory urticaria

medium confidence

Also known as: Vibratory angioedema/urticaria

Clinical definition (Orphanet)

Vibratory urticaria is a rare, genetic urticaria characterized by the development of localized, short-lasting (resolving within 1 hour), pruritic, erythematous, edematous hives in response to repetitive frictional or vibratory stimulation of the skin, which in some cases is accompanied by facial flushing, headache or the sensation of a metallic taste. Concomitant local mast cell degranulation and increased histamine serum levels are additional typical findings.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Is anyone studying this?

190

190 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.

190 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).

150 in the last 10 years · medium confidence · 76.2th percentile (publications denominator)

Is a treatment being tested?

1

trials for this specific condition

1 interventional trial matched this specific condition name; none in our sample are currently recruiting.

Data as of 26 July 2026

1 interventional trial — more than 59.2% of diseases in the trials denominator have none at all (151 of 255; this disease is at the 65.3th percentile).

medium confidence · 65.3th percentile (trials denominator)

Do we know what causes it?

Possibly — only limited evidence so far for ADGRE2.

GenCC classification: Limited.

Who's working on it?

1,451

Distinct author names in 190 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Metcalfe DD10 papers · 2021

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

    Papers in Europe PMC
  2. 02
    Lyons JJ8 papers · 2024

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

    Papers in Europe PMC
  3. 03
    Maurer M8 papers · 2025

    Department of Dermatology and Allergy, Charité - Universitätsmedizin, Berlin, Germany. Electronic address: marcus.maurer@charite.de.

    Papers in Europe PMC
  4. 04
    Lin HH6 papers · 2026

    Division of Rheumatology, Allergy, and Immunology, Chang Gung Memorial Hospital-Keelung, Keelung 20401, Taiwan.

    Papers in Europe PMC
  5. 05
    Milner JD5 papers · 2024

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD jdmilner@niaid.nih.gov.

    Papers in Europe PMC
  6. 06
    Olivera A5 papers · 2021

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

    Papers in Europe PMC
  7. 07
    Schwartz LB5 papers · 2021

    Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, Va.

    Papers in Europe PMC
  8. 08
    Ansotegui IJ4 papers · 2022

    Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Bilbao, Spain.

    Papers in Europe PMC
  9. 09
    Canonica GW4 papers · 2022

    Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.

    Papers in Europe PMC
  10. 10
    Gatica-Ortega ME4 papers · 2025

    Dermatology Department, University Hospital Complex of Toledo, Toledo, Spain.

    Papers in Europe PMC

Recruiting interventional trials

Trials testing a treatment from the matched ClinicalTrials.gov set

1 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.

"Vibratory urticaria" OR "Vibratory angioedema/urticaria" OR "dermodistortive urticaria" OR "vibratory urticaria, autosomal dominant"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Vibratory angioedema

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Vibratory urticaria" OR "Vibratory angioedema/urticaria" OR "dermodistortive urticaria" OR "vibratory urticaria, autosomal dominant" OR "Vibratory angioedema" OR "ADGRE2"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Cross-references (from Mondo): MESH:C536347 OMIM:125630 OMIM:193050

Query health: ok — strategies attempted: phrase, mesh, recall-expansion; with hits: phrase, mesh, recall-expansion

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: DDU; VBU

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 2 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus

Report an error for ORPHA:493342